bioterror
limit
militarydirect
biowarfar
develop
consider
promin
due
increas
world
threat
anthrax
outbreak
unit
state
clinician
public
health
offici
becom
awar
rare
diseas
local
state
nation
program
increas
detect
therapeut
option
respons
caus
agent
earli
recognit
bioterror
agent
difficult
sinc
earli
prodrom
phase
agent
similar
often
indistinguish
caus
febril
respiratori
ill
febril
respiratori
ill
respiratori
failur
signifi
natur
outbreak
eg
sever
acut
respiratori
syndrom
plagu
tularemia
novel
strain
influenza
bioterror
event
case
febril
respiratori
ill
admit
intens
care
unit
icu
caus
communityacquir
pneumonia
respiratori
failur
acut
respiratori
distress
syndrom
ard
subsequ
develop
communityacquir
pneumonia
case
although
case
communityacquir
pneumonia
recogniz
rare
contagi
caus
eg
plagu
larg
impact
health
care
public
health
system
thu
earli
recognit
infect
becom
import
two
reason
first
earli
infect
control
public
health
prepared
strategi
must
implement
reduc
spread
health
care
worker
public
particularli
acut
stage
diseas
patient
contagi
like
undergo
aerosolgener
diagnost
procedur
second
intent
releas
agent
bioterror
event
public
health
law
enforc
author
train
provid
immedi
investig
support
therefor
earli
suspicion
bioterror
outbreak
event
along
earli
protect
measur
public
health
contact
reduc
likelihood
transmiss
health
care
worker
visitor
patient
commun
bioterror
involv
deliber
releas
virus
bacteria
product
eg
toxin
caus
morbid
mortal
human
anim
plant
bioterror
agent
natur
occur
organ
toxin
caus
sporad
diseas
ordinari
circumst
occas
agent
manipul
increas
resist
antibiot
increas
organ
virul
chapter
provid
overview
major
agent
bioterror
highli
lethal
diseas
outbreak
along
clue
detect
step
public
health
respons
infect
control
intervent
bioterror
exist
centuri
ancient
mesopotamia
current
time
initi
goal
incapacit
enemi
death
stir
panic
popul
lead
surrend
exampl
centuri
tartar
catapult
plagueinfect
corps
kaffa
lead
diseas
spread
defeat
citi
also
start
second
wave
black
death
europ
new
world
smallpoxcontamin
blanket
may
distribut
earli
settler
nativ
effort
overcom
sieg
fort
pitt
howev
bioterror
took
form
last
year
extens
biowarfar
unit
world
war
ii
notabl
unit
japanes
armi
world
war
ii
use
anthrax
plagu
cholera
typhoid
chines
prison
high
mortal
transit
battlefield
less
success
cold
war
saw
unit
state
former
soviet
union
develop
bioweapon
stockpil
sinc
dismantl
howev
past
year
increas
individualiniti
bioterror
culmin
anthrax
outbreak
use
postal
servic
distribut
caus
case
rout
transmiss
bioterror
agent
air
eg
aerosol
gener
food
eg
botul
water
eg
gastroenter
agent
deliveri
mimic
natur
occur
diseas
especi
food
water
suppli
public
target
howev
aerosol
gener
rapid
increas
new
case
seen
lowrisk
popul
seen
anthrax
case
bioterror
agent
infecti
diseas
present
diseas
usual
covert
health
care
worker
see
initi
case
particularli
contagi
diseas
plagu
pneumonia
smallpox
viral
hemorrhag
fever
secondari
infect
may
propag
event
allow
last
week
month
stress
capac
health
care
system
chemic
explos
form
terror
howev
often
overt
immedi
known
first
respond
field
evalu
initi
case
subsequ
case
rare
follow
initi
event
therefor
epidemiolog
evid
eg
increas
pneumonia
specif
rash
may
initi
clue
bioterror
event
center
diseas
control
prevent
cdc
separ
bioterror
agent
three
broad
categori
b
c
base
eas
spread
sever
ill
categori
agent
consid
highest
risk
public
nation
secur
follow
reason
easi
persontoperson
spread
high
mortal
major
public
health
impact
caus
panic
social
disrupt
requir
specif
special
public
health
emerg
respons
eg
public
prophylaxi
protect
equip
tabl
categori
b
agent
moder
easi
spread
result
moder
morbid
low
mortal
affect
fewer
specif
public
health
respons
requir
tabl
categori
c
agent
consid
futur
potenti
threat
easili
avail
high
mortal
document
engin
success
tabl
although
agent
potenti
caus
seriou
diseas
categori
agent
along
select
categori
b
agent
would
seen
clinician
greatest
impact
public
health
care
system
agent
present
initi
nonspecif
prodrom
phase
epidemiolog
clue
may
separ
less
threaten
caus
febril
respiratori
ill
tabl
list
uniqu
featur
associ
categori
agent
clinic
syndrom
prefer
diagnost
method
radiolog
featur
treatment
infect
control
respiratori
protect
anthrax
caus
bacillu
anthraci
sporeform
gramposit
rod
b
anthraci
normal
soil
inhabit
organ
multipli
soil
condit
favor
otherwis
b
anthraci
persist
long
period
spore
form
resist
decontamin
environment
extrem
soil
b
anthraci
spread
herbivor
cattl
come
contact
sporecontain
soil
graze
human
anthrax
larg
aris
contact
anim
product
anim
skin
b
anthraci
persist
spore
unit
state
case
anthrax
due
act
bioterror
postal
system
place
anthrax
forefront
bioterror
apart
outbreak
anthrax
remain
rare
unit
state
endem
epizoot
ti
necrosi
rapid
progress
shock
death
mortal
cutan
anthrax
low
treat
patient
approxim
untreat
inhal
anthrax
carri
mortal
inhal
case
unit
state
lower
mortal
although
initi
symptom
inhal
anthrax
nonspecif
earli
find
distinguish
inhal
anthrax
influenzalik
ill
communityacquir
pneumonia
compar
patient
present
communityacquir
pneumonia
retrospect
studi
patient
inhal
anthrax
like
nausea
vomit
tachycardia
elev
transaminas
hyponatremia
normal
white
blood
cell
count
observ
score
system
devis
approxim
sensit
specif
distinguish
inhal
anthrax
case
diagnosi
anthrax
best
perform
isol
b
anthraci
cultur
blood
sputum
pleural
fluid
cerebrospin
fluid
skin
see
tabl
clinician
notifi
laboratori
suspect
anthrax
spore
form
cultur
lead
spread
laboratori
worker
properli
handl
addit
suspect
case
anthrax
involv
public
health
laboratori
confirm
strain
type
polymeras
chain
reaction
pcr
rapid
enzymelink
immunosorb
assay
elisa
avail
good
sensit
specif
radiograph
imag
find
associ
anthrax
includ
widen
mediastinum
consist
hemorrhag
mediastin
hallmark
inhal
anthrax
see
fig
see
tabl
howev
outbreak
find
includ
patchi
alveolar
opac
lobar
consolid
pleural
effus
also
report
case
widen
mediastinum
present
chest
radiograph
followup
confirm
perform
comput
tomographi
scan
treatment
includ
support
therapi
antibiot
see
tabl
intens
care
manag
earli
appropri
volum
resuscit
lungprotect
low
tidal
volum
ventil
use
indic
antibacteri
treatment
includ
ciprofloxacin
doxycyclin
isol
suscept
penicillin
rifampin
clindamycin
vancomycin
combin
ciprofloxacin
use
isol
resist
penicillin
pleural
drainag
central
nervou
ventriculoperiton
shunt
may
also
use
individu
case
corticosteroid
wide
use
reduc
edema
hemorrhag
especi
cutan
anthrax
affect
head
neck
threaten
airway
integr
limit
data
efficaci
raxibacumab
human
monoclon
antibodi
direct
b
anthraci
protect
antigen
whose
role
bind
host
cell
deliv
anthrax
edema
factor
lethal
factor
host
cell
cytoplasm
effect
treatment
anthrax
anim
model
case
seen
middl
east
case
unit
state
aris
handl
anim
product
case
associ
anim
hide
drum
skin
import
africa
diseas
begin
b
anthraci
spore
introduc
subcutan
via
ingest
inhal
introduct
oxygen
proteinrich
environ
spore
convert
veget
bacillu
form
initi
replic
exotoxin
secret
lead
local
spread
edema
hemorrhag
tissu
necrosi
anthrax
capsul
edema
factor
toxin
lethal
factor
toxin
act
concert
drive
diseas
three
clinic
diseas
syndrom
seen
anthrax
cutan
gastrointestin
inhal
cutan
anthrax
common
form
worldwid
incub
period
day
inocul
spore
subcutan
space
follow
small
painless
papul
prurit
papul
enlarg
develop
central
vesicl
follow
eros
painless
black
eschar
fig
mark
edema
mediat
anthrax
edema
toxin
characterist
surround
lesion
may
region
lymphadenopathi
system
symptom
fever
malais
hand
arm
face
neck
area
commonli
affect
inhal
anthrax
spore
reach
distal
airway
transport
inflammatori
monocyt
dendrit
cell
mediastin
lymph
node
replic
follow
onset
diseas
incub
period
averag
day
follow
clinic
symptom
nonspecif
febril
ill
often
mimick
influenza
howev
within
hour
diseas
rapidli
progress
develop
respiratori
failur
hemorrhag
mediastin
necrot
pneumonia
shock
multiorgan
failur
death
see
tabl
shock
multiorgan
failur
develop
rapidli
along
hemorrhag
mediastin
fig
clinic
hallmark
anthrax
gastrointestin
anthrax
rare
usual
seen
famili
cluster
follow
consumpt
undercook
meat
infect
anim
diseas
begin
develop
bowel
edema
follow
mesenter
lymphadeniceas
worldwid
due
increas
unvaccin
popul
along
contagi
abil
transmit
aerosol
smallpox
cdc
categori
bioterror
agent
two
stockpil
viru
known
remain
cdc
russian
state
research
center
smallpox
exist
two
form
variola
major
variola
minor
variola
major
common
form
smallpox
sever
diseas
extens
rash
fever
carri
higher
mortal
around
unvaccin
variola
minor
less
common
less
sever
mortal
estim
less
variola
minor
genet
sequenc
similar
variola
major
quantit
differ
gene
express
thought
account
variabl
mortal
major
minor
form
smallpox
infect
begin
viru
enter
respiratori
tract
replic
local
transport
region
lymph
node
viremia
follow
spread
lymphoid
organ
follow
viral
replic
progress
symptom
variola
major
present
five
major
clinic
categori
ordinari
modifi
flat
hemorrhag
variola
sine
eruption
ordinari
type
infect
account
case
smallpox
endem
incub
period
day
diseas
preerupt
phase
manifest
high
temperatur
sever
headach
malais
preerupt
phase
last
day
follow
erupt
phase
character
rash
lesion
first
appear
small
erythemat
macul
mucou
membran
tongu
face
herald
spot
lesion
spread
centrifug
fashion
macul
evolv
papul
vesicl
final
classic
pustul
pox
fig
day
rash
see
tabl
fever
usual
resolv
erupt
phase
may
persist
pustul
develop
crust
heal
begin
day
rash
modifi
type
variola
major
similar
ordinari
type
except
rash
rapid
less
sever
improv
surviv
day
raxibacumab
approv
us
food
drug
administr
fda
treatment
inhal
anthrax
use
combin
antibiot
initi
diagnosi
inhal
anthrax
suspect
confirm
anthrax
vaccin
prepar
cultur
filtrat
attenu
strain
b
anthraci
approv
human
fda
use
limit
due
need
multipl
dose
local
side
effect
efficaci
concern
current
reserv
militari
personnel
exposur
aerosol
spore
requir
prophylaxi
either
ciprofloxacin
doxycyclin
adult
amoxicillin
secondlin
agent
children
pregnant
women
recommend
durat
postexposur
prophylaxi
day
none
antibiot
erad
spore
may
germin
week
exposur
anthrax
transmit
infect
person
b
anthraci
veget
form
clinic
infect
spore
transmiss
see
tabl
contact
infect
anim
carcass
anim
product
especi
hide
result
infect
wear
appropri
person
protect
equip
ppe
indic
handl
materi
expos
suspect
contamin
object
variola
viru
caus
agent
smallpox
member
poxvirida
famili
smallpox
erad
worldwid
regain
interest
potenti
bioterror
agent
smallpox
wide
endem
one
point
account
death
worldwid
smallpox
contagi
approxim
half
unvaccin
household
contact
contract
diseas
global
erad
smallpox
declar
routin
vaccin
smallpox
mortal
vari
clinic
categori
ordinari
type
carri
mortal
multiorgan
failur
hypotens
around
flat
hemorrhag
type
carri
higher
mortal
modifi
sine
eruption
type
carri
much
lower
mortal
complic
includ
secondari
bacteri
skin
infect
pneumonia
along
enceph
orchiti
extens
scar
skin
cornea
spread
contact
infect
lesion
respiratori
secret
thu
full
ppe
includ
respiratori
protect
gown
glove
face
shield
requir
cdc
guidelin
recommend
airborn
isol
use
particul
respir
power
airpurifi
respir
respiratori
protect
health
care
worker
involv
care
smallpox
patient
must
vaccin
smallpox
see
tabl
smallpox
suspect
public
health
offici
must
contact
immedi
yersinia
pesti
etiolog
agent
plagu
caus
multipl
pandem
despit
recent
evolv
pathogen
plagu
zoonosi
primarili
affect
rodent
human
anim
especi
domest
cat
accident
host
natur
ecosystem
pesti
depend
larg
flearod
interact
season
variat
base
environment
condit
favor
larg
rodent
popul
infect
flea
bite
rodent
host
inocul
rodent
mortal
anim
lower
nonrod
mammal
diseas
pass
infect
rodent
flea
life
cycl
continu
pesti
transmit
human
bite
rodentinfect
flea
scratch
bite
infect
anim
exposur
infect
human
bioterror
bite
infect
flea
common
mode
transmiss
squirrel
rabbit
domest
wild
cat
prairi
dog
common
sourc
infect
flea
larg
rodent
anim
dieoff
particularli
suscept
speci
may
herald
larg
epidem
natur
plagu
found
worldwid
unit
state
endem
diseas
concentr
western
state
like
introduct
pestisinfect
rat
port
san
francisco
lo
angel
seattl
late
centuri
three
clinic
syndrom
associ
plagu
bubon
plagu
case
septicem
plagu
case
pneumon
plagu
rare
incub
period
day
symptom
usual
aris
differ
depend
clinic
syndrom
incub
period
prolong
asymptomat
due
multipl
mechan
use
pesti
minim
earli
innat
immun
respons
inflamm
includ
specif
inhibit
inflammasom
activ
bubon
plagu
sudden
onset
fever
chill
headach
follow
pain
swell
region
lymph
node
proxim
site
bite
scratch
type
common
vaccin
individu
flat
type
pustul
remain
flat
confluent
often
seen
children
hemorrhag
type
rare
sever
lesion
mucou
membran
becom
hemorrhag
type
common
pregnant
women
led
multiorgan
failur
within
day
variola
sine
eruption
type
associ
fever
rash
type
often
seen
previous
vaccin
individu
diagnosi
larg
clinic
acut
onset
fever
follow
characterist
rash
deepseat
vesicl
pustul
see
tabl
laboratori
diagnosi
variolaand
orthopoxspecif
pcr
assay
perform
cdc
world
health
organizationsponsor
laboratori
case
smallpox
suspect
inform
diagnosi
infect
control
public
health
measur
avail
http
emergencycdcgovagentsmallpox
responseplanindexasp
radiograph
imag
find
smallpox
limit
larg
diffus
alveolar
opac
inflammatori
respons
associ
primari
infect
see
tabl
lobar
opac
may
seen
often
associ
secondari
bacteri
pneumonia
treatment
larg
support
evid
cidofovir
antivir
activ
cytomegaloviru
activ
anim
model
see
tabl
aggress
icu
support
includ
volum
resuscit
vasopressor
support
low
tidal
volum
ventil
use
sever
case
vaccin
soon
possibl
exposur
may
reduc
sever
ill
mainstay
reduc
spread
control
diseas
commun
vaccin
administ
within
day
exposur
still
provid
protect
passiv
immun
vaccinia
immun
globulin
fda
approv
patient
suffer
progress
vaccinia
infect
vaccin
whether
efficaci
treat
smallpox
determin
doxycyclin
also
suscept
ciprofloxacin
although
less
clinic
experi
drug
plagu
chloramphenicol
prefer
case
mening
due
abil
cross
bloodbrain
barrier
case
primari
pneumonia
lead
multiorgan
failur
acut
lung
injuri
volum
resuscit
vasopressor
support
low
tidal
volum
ventil
indic
evid
benefit
corticosteroid
postexposur
prophylaxi
includ
ciprofloxacin
doxycyclin
oral
trimethoprimsulfamethoxazol
isol
index
case
suscept
gentamicin
children
pregnant
individu
due
high
rate
transmiss
plagu
via
aerosol
patient
strict
airborn
isol
least
hour
antibiot
given
see
tabl
infect
control
measur
includ
airborn
isol
includ
negativepressur
ventil
appropri
ppe
includ
mask
power
airpurifi
respir
worn
personnel
contact
patient
suspect
confirm
pneumon
plagu
tularemia
caus
gramneg
bacterium
francisella
tularensi
zoonot
diseas
human
accident
host
f
tularensi
found
throughout
northern
hemispher
wide
varieti
wild
domest
speci
organ
persist
natur
human
becom
infect
bite
infect
vector
tick
fli
handl
infect
anim
ingest
improperli
prepar
anim
meat
anim
scratch
bite
drink
contamin
water
inhal
aerosol
organ
environ
bioterror
event
humantohuman
transmiss
describ
six
distinct
clinic
syndrom
observ
tularemia
ulceroglandular
glandular
typhoid
pneumon
oropharyng
oculoglandular
ulceroglandular
diseas
account
approxim
case
incub
period
day
abrupt
onset
fever
chill
headach
malais
patient
singl
papuloulc
lesion
central
eschar
associ
tender
lymphadenopathi
fig
glandular
diseas
lymph
node
enlarg
without
characterist
lesion
case
pneumon
tularemia
result
primari
inhal
hematogen
spread
typhoid
tularemia
expect
main
clinic
present
bioterror
event
tularemia
incub
period
tend
shorter
case
rapid
onset
pneumonia
respiratori
failur
ard
develop
rapidli
see
tabl
typhoid
tularemia
rare
seen
without
pneumonia
patient
present
febril
ill
follow
sepsi
without
glandular
diseas
oropharyng
tularemia
result
undercook
infect
meat
water
lymph
node
bubo
character
intens
tender
erythema
edema
without
fluctuat
fig
without
treatment
diseas
dissemin
lead
pneumonia
mening
sepsi
multiorgan
failur
develop
secondari
plagu
pneumonia
import
detect
patient
highli
contagi
septicem
plagu
acut
fever
follow
sepsi
without
bubo
addit
symptom
nausea
vomit
diarrhea
also
complic
septicem
plagu
sepsi
dissemin
intravascular
coagul
multiorgan
failur
develop
quickli
pneumon
plagu
case
secondari
hematogen
bubon
septicem
plagu
primari
pneumon
plagu
also
develop
exposur
infect
human
anim
aerosol
intent
bioterror
attack
initi
case
outbreak
primari
pneumon
plagu
short
incub
period
hour
day
follow
sudden
onset
fever
cough
rapid
onset
respiratori
failur
ard
death
see
tabl
clinic
diagnosi
plagu
difficult
exposur
anim
endem
area
import
clue
seek
see
tabl
intent
dissemin
multipl
case
sever
rapidli
progress
pneumonia
may
first
sign
attack
laboratori
diagnosi
primarili
cultur
sputum
blood
pesti
grow
well
routin
laboratori
media
serolog
rapid
diagnost
test
elisa
pcr
also
avail
use
primarili
field
test
chest
radiograph
sudden
diffus
alveolar
fill
process
seen
consist
acut
lung
injuri
see
tabl
addit
mediastin
lymphadenopathi
may
present
may
pleural
effus
later
stage
lobar
opac
less
common
primari
agent
antibacteri
therapi
plagu
long
consid
streptomycin
base
limit
avail
gentamicin
doxycyclin
prefer
see
tabl
isol
suscept
gentamicin
clostridium
botulinum
gramposit
sporeform
oblig
anaerob
bacterium
produc
excret
botulinum
toxin
neurotoxin
respons
clinic
diseas
known
botul
categori
agent
toxin
seven
serotyp
botulinum
toxin
exist
g
produc
differ
strain
c
botulinum
botulinum
neurotoxin
act
proteas
cleav
protein
synapt
vesicl
presynapt
plasma
membran
neuromuscular
junction
cholinerg
autonom
synaps
result
inabl
releas
neurotransmitt
disrupt
neurotransmiss
account
clinic
find
serotyp
b
e
predomin
human
diseas
although
serotyp
caus
diseas
serotyp
c
predomin
found
anim
popul
botulinum
toxin
extrem
potent
median
lethal
oral
dose
estim
ngkg
although
lethal
dose
may
two
three
time
higher
exposur
inhal
diseas
present
four
potenti
sourc
foodborn
wound
infant
intent
foodborn
diseas
present
outbreak
often
associ
homecan
food
fruit
veget
ferment
fish
wound
botul
associ
intraven
subcutan
inject
black
tar
heroin
mostli
mexican
origin
infant
botul
seen
sporad
western
state
like
spore
acquisit
soil
raw
honey
toxin
product
gastrointestin
tract
final
intent
releas
bioterror
event
may
lead
oral
ingest
inhal
toxin
botul
begin
acut
onset
bilater
cranial
neuropathi
rapidli
descend
weak
see
tabl
fever
present
mental
statu
affect
cranial
neuropathi
usual
symmetr
often
begin
oculomotor
dysfunct
howev
asymmetr
cranial
nerv
dysfunct
report
diplopia
dysphagia
ptosi
facial
weak
common
earli
complaint
foodborn
exposur
may
also
gastrointestin
symptom
includ
nausea
vomit
infant
botul
poor
feed
lethargi
may
symptom
foodborn
botul
usual
onset
symptom
hour
exposur
symptom
rapidli
progress
next
hour
botul
suspect
treatment
start
rapidli
weak
paralysi
respiratori
muscl
ensu
requir
mechan
ventilatori
support
muscl
respir
involv
mechan
support
may
requir
month
sinc
toxinmedi
blockad
neuromuscular
transmiss
revers
full
recoveri
expect
although
recoveri
may
prolong
earli
prompt
diagnosi
essenti
respiratori
support
often
requir
earli
treatment
may
alter
extent
progress
weak
thu
clinic
find
cranial
nerv
palsi
particularli
appropri
clinic
set
eg
heroin
use
ingest
ingest
associ
fever
pharyng
cervic
lymphadenopathi
oculoglandular
tularemia
result
direct
inocul
contamin
finger
accident
exposur
conjunctiv
swell
erythema
region
lymphadenopathi
may
present
cultur
f
tularensi
suboptim
respect
specif
cultur
media
cystein
requir
growth
slow
cultur
hazard
laboratori
personnel
see
tabl
chapter
tabl
pcr
detect
f
tularensi
rapid
hazard
report
sensit
approxim
high
specif
see
tabl
pcrposit
fresh
sampl
submit
refer
public
health
laboratori
confirm
radiograph
imag
studi
show
patchi
opac
bilater
lobar
diseas
hilar
adenopathi
see
tabl
also
pleural
effus
miliari
pattern
hilar
mediastin
adenopathi
similar
treatment
plagu
gentamicin
treatment
choic
tularemia
see
tabl
doxycyclin
ciprofloxacin
may
use
secondlin
therapi
mening
chloramphenicol
prefer
postexposur
prophylaxi
doxycyclin
ciprofloxacin
may
efficaci
trimethoprimsulfamethoxazol
amoxicillin
children
pregnant
patient
icu
manag
tularemia
includ
support
care
low
tidal
volum
ventil
ard
overal
mortal
tularemia
around
thought
higher
aerosol
diseas
caus
pneumonia
typhoid
tularemia
tularemia
spread
humantohuman
contact
diagnosi
confirm
respiratori
isol
discontinu
see
tabl
rule
report
tularemia
public
health
offici
vari
across
north
america
pneumon
typhoid
case
particularli
thought
secondari
bioterror
event
must
report
virus
caus
bolivian
machupo
viru
argentin
junin
viru
hemorrhag
fever
famili
arenavirida
crimeancongo
rift
valley
fever
virus
belong
bunyavirida
famili
filovirida
ebola
marburg
virus
arenavirida
list
categori
agent
filovirida
famili
serv
classic
templat
viral
hemorrhag
fever
larg
discuss
marburg
viru
singl
speci
ebola
viru
five
differ
speci
vari
virul
human
transmiss
appear
contact
blood
secret
nonhuman
primat
infect
individu
peopl
becom
infect
handl
primat
product
consum
nonhuman
primat
meat
exposur
symptomat
patient
includ
hospit
sever
case
present
due
exposur
laboratori
use
hemorrhag
fever
virus
bioterror
agent
also
postul
larg
base
high
contagi
aerosol
primat
model
anim
reservoir
virus
initi
thought
wild
primat
recent
tent
identifi
bat
transmit
infect
nonhuman
primat
wild
clinic
manifest
marburg
ebola
virus
similar
present
pathophysiolog
incub
period
exposur
either
viru
usual
day
may
long
day
clinic
diseas
begin
abrupt
onset
fever
chill
malais
sever
headach
nausea
vomit
diarrhea
abdomin
pain
next
day
symptom
worsen
includ
prostrat
stupor
hypotens
patient
coagul
becom
impair
appear
increas
conjunctiv
soft
tissu
bleed
report
outbreak
hemorrhag
massiv
gastrointestin
urinari
tract
rare
instanc
lung
outbreak
ebola
viru
diseas
center
guinea
liberia
sierra
leon
hemorrhag
promin
instead
clinic
pictur
domin
volumin
diarrhea
onset
maculopapular
rash
arm
trunk
may
distinct
sign
fig
along
volum
deplet
hypotens
multiorgan
failur
develop
often
lead
death
see
tabl
outbreak
case
larg
describ
develop
countri
critic
care
resourc
limit
thu
experi
mechan
ventil
develop
ard
well
document
casefat
rate
rang
import
suspect
diagnosi
viral
hemorrhag
fever
order
initi
support
care
onset
shock
involv
public
health
depart
implement
infect
control
measur
viral
hemorrhag
fever
suspect
case
expos
laboratori
worker
acut
ill
travel
endem
area
ie
central
west
africa
presenc
characterist
clinic
find
context
case
commun
suggest
bioterror
attack
presenc
high
temperatur
malais
joint
pain
conjunctiv
bleed
bruis
vomit
diarrhea
food
anoth
person
botul
prompt
consider
botul
see
tabl
laboratori
diagnosi
toxin
detect
organ
isol
detect
toxin
blood
stool
reliabl
growth
c
botulinum
stool
wound
sampl
correspond
clinic
find
also
confirm
diagnosi
electromyographi
also
support
diagnosi
toxin
organ
isol
unsuccess
specif
radiolog
chang
seen
botul
low
lung
volum
chest
radiograph
may
seen
specif
see
tabl
support
care
cornerston
manag
botul
monitor
impend
respiratori
failur
provid
mechan
ventil
need
highest
prioriti
equin
trival
antitoxin
serotyp
b
e
avail
state
public
health
depart
cdc
direct
neutral
toxin
yet
enter
cell
botulinum
antitoxin
revers
botulinum
intox
see
tabl
antitoxin
wide
use
case
botul
efficaci
infer
sinc
avail
antitoxin
deriv
immun
hors
anaphylaxi
andor
serum
sick
develop
recipi
humanderiv
antitoxin
avail
infant
botul
human
monoclon
antibodi
prepar
neutral
multipl
type
botulinum
toxin
provid
potenti
use
adult
lower
risk
advers
effect
equin
antiserum
wound
botul
wound
drainag
antibiot
administr
use
penicillin
clindamycin
drug
choic
foodborn
inhal
botul
diseas
result
exposur
toxin
infect
antibiot
efficaci
case
botul
routin
monitor
forc
vital
capac
recommend
earli
intub
vital
capac
fall
mlkg
approxim
predict
direct
prophylaxi
exposur
set
highrisk
threat
vaccin
direct
serotyp
e
avail
larg
use
militari
patient
die
botul
due
respiratori
failur
without
ventilatori
support
complic
critic
care
botul
toxinbas
diseas
specif
infect
control
measur
requir
see
tabl
exposur
spore
toxin
follow
decontamin
although
secondari
infect
intox
medic
personnel
report
hemorrhag
fever
virus
includ
multipl
geograph
distribut
virus
includ
ebola
marburg
virus
virus
caus
rift
valley
fever
bolivian
argentin
crimeancongo
hemorrhag
fever
lassa
fever
yellow
fever
dengu
fever
ebola
marburg
virus
famili
filovirida
lassa
viru
patient
mandat
stringent
precaut
protect
personnel
placement
patient
isol
room
strict
procedur
handl
wast
essenti
protect
healthcar
personnel
see
tabl
equip
dedic
individu
higher
risk
procedur
must
done
full
ppe
suspect
case
viral
hemorrhag
fever
immedi
involv
public
health
offici
infect
control
depart
public
health
intervent
outbreak
investig
essenti
reduc
spread
diseas
within
commun
investig
potenti
bioterror
attack
glander
caus
gramneg
bacterium
burkholderia
mallei
primarili
diseas
hors
human
becom
infect
broken
skin
droplet
inhal
natur
occur
human
infect
rare
occup
case
princip
hors
veterinarian
seen
sporad
bioterror
aerosol
anticip
method
exposur
glander
present
acut
chronic
skin
infect
aerosol
rapid
pneumonia
andor
sepsi
result
diagnosi
cultur
b
mallei
misclassifi
autom
system
pseudomona
speci
treatment
includ
support
care
well
system
antibiot
thirdgener
cephalosporin
imipenem
ciprofloxacin
humantohuman
transmiss
detect
univers
precaut
droplet
isol
respiratori
case
recommend
suspect
case
prompt
immedi
notif
public
health
depart
melioidosi
caus
gramneg
bacterium
burkholderia
pseudomallei
unlik
b
mallei
bacterium
natur
reservoir
soil
contamin
water
spread
direct
contact
inhal
thu
diseas
predomin
raini
season
bioterror
aerosol
would
lead
clinic
pictur
pneumonia
melioidosi
sepsi
melioidosi
incub
period
highli
variabl
case
present
acut
extend
incub
period
other
remain
asymptomat
sepsi
multipl
metastat
foci
develop
symptomat
case
eventu
progress
multiorgan
failur
diagnosi
cultur
use
routin
method
treatment
involv
imipenem
thirdgener
cephalosporin
follow
treatment
doxycyclin
trimethoprimsulfamethoxazol
erad
metastat
foci
psittacosi
caus
chlamydophila
psittaci
intracellular
bacterium
routin
associ
bird
parrot
cockatiel
canari
psittacosi
present
confus
progress
shock
multiorgan
failur
rais
suspicion
viral
hemorrhag
fever
laboratori
diagnosi
consist
viral
nucleic
acid
detect
pcr
see
tabl
radiolog
chang
includ
diffus
alveolar
process
consist
acut
lung
injuri
see
tabl
diseas
progress
alveolar
process
becom
dens
alveolar
hemorrhag
develop
pleural
effus
may
also
present
current
patient
manag
includ
support
care
includ
agress
volum
resuscit
lungprotect
strategi
low
tidal
volum
ventil
ard
part
diseas
cours
see
tabl
recent
experi
nonhuman
primat
establish
therapeut
efficaci
combin
three
monoclon
antibodi
ebola
glycoprotein
provid
proof
principl
specif
treatment
ebola
infect
possibl
human
monoclon
antibodi
may
progress
avail
human
use
arenaviru
group
lassa
junin
machupo
virus
bunyavirida
crimeancongo
hemorrhag
fever
rift
valley
fever
virus
ribavirin
recommend
recent
find
ebola
replic
requir
abelson
tyrosin
kinas
cabl
cabl
kinas
inhibitor
current
use
treatment
chronic
myelogen
leukemia
certain
malign
block
ebola
replic
vitro
suggest
addit
potenti
treatment
approach
health
care
worker
expos
approv
postexposur
prophylaxi
infect
control
occup
health
personnel
involv
immedi
two
distinct
vaccin
protect
nonhuman
primat
ebola
challeng
enter
initi
trial
human
transmiss
droplet
rout
high
viral
load
found
blood
diarrhea
secret
ebola
brucellosi
caus
number
speci
within
genu
brucella
diseas
common
livestock
worker
particularli
area
poor
sanit
brucella
found
domest
anim
brucella
categori
b
agent
due
low
mortal
prolong
incub
period
exposur
ingest
contamin
food
intent
aerosol
symptom
develop
week
month
initi
fever
persist
irregularli
week
month
follow
arthralgia
gastrointestin
symptom
possibl
endocard
diagnosi
suspect
plausibl
histori
exposur
isol
organ
blood
cultur
howev
growth
slow
cultur
kept
week
diagnosi
suspect
treatment
doxycyclin
week
children
treatment
trimethoprimsulfamethoxazol
children
clostridium
speci
produc
multipl
toxin
epsilon
toxin
produc
clostridium
perfringen
type
b
toxin
act
host
cell
membran
produc
pore
caus
nonselect
permeabl
clostridium
perfringen
use
toxin
gain
access
bloodstream
gut
howev
bioterror
intent
releas
via
ingest
inhal
toxin
alon
like
base
data
anim
rapid
ingest
inhal
would
caus
diffus
tissu
edema
manifest
central
nervou
system
dysfunct
weak
ataxia
confus
pulmonari
edema
short
breath
cough
bronchospasm
respiratori
failur
nausea
vomit
tachycardia
hypotens
diagnosi
requir
clinic
suspicion
consist
bioterror
attack
toxin
detect
elisa
treatment
support
penicillin
c
perfringen
present
addit
toxin
food
safeti
threat
eg
salmonella
speci
escherichia
coli
shigella
enteropathogen
gramneg
bacteria
escherichia
coli
salmonella
shigella
constitut
larg
group
agent
make
food
suppli
threat
public
health
offici
familiar
bacteria
numer
episod
food
contamin
lead
local
outbreak
larg
product
recal
intent
releas
agent
would
produc
widespread
gastrointestin
symptom
lead
signific
morbid
low
mortal
incub
period
day
would
abdomin
cramp
nausea
vomit
diarrhea
diarrhea
may
volumin
bloodi
diagnosi
stool
cultur
agent
aggress
public
health
investig
usual
yield
initi
agent
bioterror
resembl
pointsourc
outbreak
treatment
intraven
hydrat
need
agent
salmonella
shigella
antibacteri
therapi
ciprofloxacin
nonspecif
case
go
undiagnos
categori
b
bioterror
agent
c
psittaci
caus
morbid
low
mortal
intent
aerosol
would
lead
multipl
case
nonspecif
atyp
pneumonia
cough
fever
headach
diagnosi
histor
difficult
sensit
pcr
techniqu
offer
potenti
rapid
specif
diagnosi
see
chapter
tabl
treatment
doxycyclin
macrolid
ciprofloxacin
mortal
low
treat
case
univers
precaut
requir
patient
care
although
mask
coveral
recommend
environment
decontamin
q
fever
zoonot
diseas
caus
coxiella
burnetii
cattl
sheep
goat
primari
reservoir
c
burnetii
diseas
found
worldwid
coxiella
burnetii
usual
caus
clinic
diseas
anim
organ
found
milk
urin
fece
amniot
fluid
placenta
organ
resist
heat
dri
caus
infect
inhal
environment
dust
contamin
dri
placent
materi
birth
fluid
excrement
incub
time
week
clinic
ill
develop
approxim
infect
person
q
fever
character
high
temperatur
often
greater
sever
headach
myalgia
sore
throat
nonproduct
cough
nausea
vomit
diarrhea
abdomin
pain
chest
pain
pneumonia
develop
patient
symptomat
infect
one
percent
peopl
acut
q
fever
die
diseas
small
percentag
infect
chronic
q
fever
infect
persist
month
includ
endocard
develop
person
chronic
q
fever
die
diseas
diagnosi
q
fever
depend
serolog
test
commonli
use
indirect
immunofluoresc
assay
see
chapter
tabl
antibiot
treatment
choic
acut
q
fever
doxycyclin
mg
twice
daili
day
fluoroquinolon
may
effect
altern
ricin
potent
biolog
toxin
toxic
protein
deriv
castor
bean
ricinu
communi
manufactur
castor
oil
ricin
act
toxin
inhibit
protein
synthesi
mg
gram
thought
lethal
dose
symptom
begin
within
hour
exposur
system
effect
ricin
poison
depend
rout
exposur
exposur
dosag
sign
symptom
oral
ingest
includ
vomit
profus
diarrhea
addit
may
fever
myalgia
arthralgia
hallucin
seizur
hypovolem
shock
multiorgan
failur
may
interven
repres
like
caus
death
base
anim
experi
inhal
exposur
symptom
human
expect
includ
cough
respiratori
distress
bronchoconstrict
influenzalik
symptom
fever
myalgia
arthralgia
may
seen
hypotens
respiratori
failur
multiorgan
failur
symptom
sign
exist
separ
ricin
intox
caus
respiratori
failur
although
excess
diaphoresi
report
would
unusu
caus
present
nonspecif
symptom
figur
outlin
approach
earli
isol
test
involv
institut
infect
control
public
health
offici
case
acut
febril
ill
upon
admiss
case
acut
febril
ill
respiratori
failur
undergo
initi
diagnost
test
includ
pretreat
gram
stain
respiratori
cultur
urin
antigen
test
legionella
etiolog
agent
identifi
initi
screen
clinic
find
ie
gramposit
diplococci
lobar
pneumonia
radiograph
target
treatment
initi
appropri
isol
precaut
base
pathogen
howev
agent
easili
identifi
patient
place
isol
diagnost
test
perform
multipl
case
similar
symptom
case
uncommon
epidemiolog
link
determin
patient
isol
public
health
offici
contact
specif
clinic
featur
subsequ
aris
direct
diagnost
test
perform
clear
etiolog
detect
evalu
warrant
invas
expand
test
staphylococc
enterotoxin
b
toxin
produc
staphylococcu
aureu
commonli
associ
food
poison
symptom
food
poison
includ
vomit
diarrhea
sever
hour
ingest
food
natur
occur
rare
lethal
clinic
present
would
depend
rout
administr
oral
administr
poison
food
water
suppli
would
present
vomit
diarrhea
inhal
respiratori
failur
neurotox
effect
may
seen
new
variant
influenza
viru
emerg
caus
global
influenza
pandem
treatment
strategi
intervent
use
pandem
impact
plan
respons
highli
infecti
agent
includ
agent
potenti
bioterror
administr
antivir
particularli
oseltamivir
reduc
hospit
death
administ
within
hour
symptom
onset
critic
ill
patient
pandem
influenza
oseltamivir
associ
increas
surviv
compar
treatment
versu
median
time
treatment
initi
day
symptom
onset
howev
treatment
initi
within
day
symptom
onset
still
associ
increas
surviv
compar
therapi
similar
find
seen
children
atrisk
individu
includ
immunocompromis
pregnant
women
therefor
import
earli
distribut
administr
therapi
includ
rapid
dissemin
therapi
guidelin
practition
must
cornerston
bioterror
respons
addit
adjunct
therapi
pandem
also
becam
cornerston
respons
includ
use
extracorpor
membran
oxygen
use
patient
ard
predomin
singl
organ
failur
result
pandem
influenza
small
observ
studi
suggest
mortal
benefit
patient
receiv
extracorpor
membran
oxygen
howev
extracorpor
membran
oxygen
perform
special
center
resourc
intens
thu
requir
region
statewid
coordin
order
ensur
success
addit
therapi
corticosteroid
inhal
nitric
oxid
nacetyl
cystein
prone
also
administ
without
establish
benefit
recognit
case
diseas
relat
bioterror
event
reli
high
index
suspicion
clinician
howev
recognit
may
difficult
earli
stage
diseas
mani
categori
agent
casualti
immedi
critic
area
respons
contrast
categori
agent
spread
contact
respiratori
transmiss
new
case
seen
initi
outbreak
case
progress
cumul
number
case
sever
respiratori
ill
increas
potenti
stress
critic
care
system
lead
sustain
need
emerg
mass
critic
care
emcc
week
month
sustain
emcc
lead
deplet
critic
care
resourc
mechan
ventil
special
train
staff
antibiot
antivir
icu
bed
thu
uniqu
issu
associ
sustain
emcc
led
improv
plan
respons
bioterror
emerg
infecti
diseas
outbreak
recent
consensu
statement
recommend
special
critic
care
prepared
includ
icu
capac
expans
critic
care
resourc
storag
coordin
critic
care
across
commun
region
statewid
level
capac
critic
care
approxim
three
time
normal
icu
capac
critic
ill
patient
locat
acut
care
hospit
less
sever
ill
patient
divert
altern
site
within
commun
hospit
enough
suppli
day
critic
ill
patient
along
plan
expand
care
noncrit
care
specialist
case
shortag
icu
admiss
limit
sever
ill
importantli
establish
triag
mechan
requir
alloc
scarc
resourc
sustain
emcc
identifi
critic
resourc
mechan
ventil
medic
oxygen
triag
mechan
shift
focu
critic
care
optim
care
individu
optim
care
popul
would
identifi
critic
ill
patient
may
get
specif
scarc
resourc
period
limit
suppli
outbreak
would
includ
inclus
exclus
criteria
icu
admiss
along
triag
score
mechan
patient
assess
sequenti
organ
failur
assess
score
valuabl
due
valu
sequenti
assess
eas
use
given
lower
relianc
laboratori
data
addit
triag
score
system
may
warrant
futur
outbreak
diseas
outbreak
condit
chang
although
bronchoscopi
gener
aerosol
increas
risk
transmiss
bronchoscopi
perform
appropri
protect
personnel
case
identif
etiolog
ill
essenti
compon
appropri
public
health
respons
public
health
author
institut
infect
control
contact
earli
possibl
clinic
suspicion
bioterror
aris
diagnost
test
yield
result
bioterror
agent
suspect
diagnosi
confirm
special
public
health
laboratori
initi
case
must
meet
case
definit
suspect
agent
see
http
emergencycdcgovbioterrorismcasedefasp
evalu
order
meet
case
definit
least
one
critic
distinguish
featur
must
met
along
clinic
laboratori
featur
involv
institut
infect
control
microbiolog
public
health
expert
must
initi
earli
possibl
notifi
one
four
condit
clinic
epidemiolog
featur
suggest
bioterror
see
tabl
unexpect
clinic
link
increas
number
case
eg
pneumonia
respiratori
failur
extens
workup
febril
respiratori
ill
fail
reveal
organ
infecti
diseas
suspect
transmiss
diseas
health
care
worker
hospit
infect
control
assist
isol
health
care
worker
protect
hospit
microbiolog
laboratori
notifi
suspect
pathogen
allow
worker
protect
target
test
sampl
final
public
health
involv
allow
broader
diagnost
test
includ
subtyp
resist
test
agent
novel
emerg
pathogen
seen
sever
acut
respiratori
syndrom
avian
influenza
earli
public
health
involv
allow
rapid
laboratori
test
epidemiolog
investig
case
definit
commun
prevent
basic
infect
control
requir
outlin
tabl
anthrax
botul
categori
agent
contagi
requir
respiratori
protect
caregiv
number
case
exce
health
care
capac
isol
patient
cohort
accessori
isol
measur
use
final
higher
risk
procedur
limit
case
tabl
aerosolgener
procedur
common
icu
patient
reduc
unnecessari
riski
procedur
reduc
patient
health
care
worker
risk
howev
procedur
perform
need
appropri
ppe
worn
health
care
worker
time
worn
properli
reduc
risk
diseas
transmiss
act
convent
terror
explos
devic
chemic
attack
result
singl
point
mass
bioterror
emerg
infecti
diseas
present
uniqu
differ
diagnost
treatment
challeng
categori
agent
consid
highest
risk
public
nation
secur
follow
reason
easi
persontoperson
spread
high
mortal
major
public
health
impact
caus
panic
social
disrupt
requir
specif
special
public
health
emerg
respons
eg
public
prophylaxi
protect
equip
diseas
caus
agent
initi
present
nonspecif
prodrom
develop
sever
diseas
specif
epidemiolog
hallmark
categori
agent
anthrax
smallpox
plagu
tularemia
botul
viral
hemorrhag
fever
eg
ebola
lassa
categori
b
agent
divers
carri
lower
morbid
mortal
pulmonari
manifest
categori
c
agent
potenti
futur
use
bioterror
agent
earli
recognit
reli
astut
clinician
earli
involv
public
health
institut
infect
control
personnel
reduc
spread
health
care
worker
commun
aggress
support
care
mainstay
critic
ill
patient
infect
bioterror
agent
target
therapi
develop
inhal
anthrax
raxibacumab
human
monoclon
antibodi
direct
b
anthraci
protect
antigen
approv
use
use
combin
antibiot
